img

Global Stomach Cancer and Gastric Cancer Drugs Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Stomach Cancer and Gastric Cancer Drugs Market Insights, Forecast to 2034

Stomach cancer is the fifth most common cancer in the world
Market Analysis and InsightsGlobal Stomach Cancer and Gastric Cancer Drugs Market
Global Stomach Cancer and Gastric Cancer Drugs market is expected to reach to US$ 4438 million in 2024, with a positive growth of %, compared with US$ 3948 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Stomach Cancer and Gastric Cancer Drugs industry is evaluated to reach US$ 9059.7 million in 2029. The CAGR will be 12.6% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Stomach Cancer and Gastric Cancer Drugs market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Stomach Cancer and Gastric Cancer Drugs market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Ipsen Pharma
Merck & Co., Inc.
Bristol-Myers Squibb Company
Eli Lilly
Roche
Novartis AG
Bayer AG
Celltrion Inc.
TAIHO PHARMACEUTICAL CO., LTD.
Jiangsu Hengrui Medicine Co., Ltd.
Segment by Type
Programmed Cell Death Protein 1 (PD-1) Inhibitors
Human Epidermal Growth Factor Receptor (HER2) Antagonists
Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
Others

Segment by Application


Hospitals
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Stomach Cancer and Gastric Cancer Drugs introduction, etc. Stomach Cancer and Gastric Cancer Drugs Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Stomach Cancer and Gastric Cancer Drugs
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stomach Cancer and Gastric Cancer Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Programmed Cell Death Protein 1 (PD-1) Inhibitors
1.2.3 Human Epidermal Growth Factor Receptor (HER2) Antagonists
1.2.4 Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
1.2.5 Others
1.3 Market by Application
1.3.1 Global Stomach Cancer and Gastric Cancer Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stomach Cancer and Gastric Cancer Drugs Market Perspective (2018-2029)
2.2 Global Stomach Cancer and Gastric Cancer Drugs Growth Trends by Region
2.2.1 Stomach Cancer and Gastric Cancer Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Stomach Cancer and Gastric Cancer Drugs Historic Market Size by Region (2018-2024)
2.2.3 Stomach Cancer and Gastric Cancer Drugs Forecasted Market Size by Region (2024-2029)
2.3 Stomach Cancer and Gastric Cancer Drugs Market Dynamics
2.3.1 Stomach Cancer and Gastric Cancer Drugs Industry Trends
2.3.2 Stomach Cancer and Gastric Cancer Drugs Market Drivers
2.3.3 Stomach Cancer and Gastric Cancer Drugs Market Challenges
2.3.4 Stomach Cancer and Gastric Cancer Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Stomach Cancer and Gastric Cancer Drugs by Players
3.1.1 Global Stomach Cancer and Gastric Cancer Drugs Revenue by Players (2018-2024)
3.1.2 Global Stomach Cancer and Gastric Cancer Drugs Revenue Market Share by Players (2018-2024)
3.2 Global Stomach Cancer and Gastric Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Stomach Cancer and Gastric Cancer Drugs, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Stomach Cancer and Gastric Cancer Drugs Market Concentration Ratio
3.4.1 Global Stomach Cancer and Gastric Cancer Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stomach Cancer and Gastric Cancer Drugs Revenue in 2022
3.5 Global Key Players of Stomach Cancer and Gastric Cancer Drugs Head office and Area Served
3.6 Global Key Players of Stomach Cancer and Gastric Cancer Drugs, Product and Application
3.7 Global Key Players of Stomach Cancer and Gastric Cancer Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Stomach Cancer and Gastric Cancer Drugs Breakdown Data by Type
4.1 Global Stomach Cancer and Gastric Cancer Drugs Historic Market Size by Type (2018-2024)
4.2 Global Stomach Cancer and Gastric Cancer Drugs Forecasted Market Size by Type (2024-2029)
5 Stomach Cancer and Gastric Cancer Drugs Breakdown Data by Application
5.1 Global Stomach Cancer and Gastric Cancer Drugs Historic Market Size by Application (2018-2024)
5.2 Global Stomach Cancer and Gastric Cancer Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Stomach Cancer and Gastric Cancer Drugs Market Size (2018-2029)
6.2 North America Stomach Cancer and Gastric Cancer Drugs Market Size by Type
6.2.1 North America Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2018-2024)
6.2.2 North America Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2024-2029)
6.2.3 North America Stomach Cancer and Gastric Cancer Drugs Market Share by Type (2018-2029)
6.3 North America Stomach Cancer and Gastric Cancer Drugs Market Size by Application
6.3.1 North America Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2018-2024)
6.3.2 North America Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2024-2029)
6.3.3 North America Stomach Cancer and Gastric Cancer Drugs Market Share by Application (2018-2029)
6.4 North America Stomach Cancer and Gastric Cancer Drugs Market Size by Country
6.4.1 North America Stomach Cancer and Gastric Cancer Drugs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2018-2024)
6.4.3 North America Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Stomach Cancer and Gastric Cancer Drugs Market Size (2018-2029)
7.2 Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Type
7.2.1 Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2018-2024)
7.2.2 Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2024-2029)
7.2.3 Europe Stomach Cancer and Gastric Cancer Drugs Market Share by Type (2018-2029)
7.3 Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Application
7.3.1 Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2018-2024)
7.3.2 Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2024-2029)
7.3.3 Europe Stomach Cancer and Gastric Cancer Drugs Market Share by Application (2018-2029)
7.4 Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Country
7.4.1 Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2018-2024)
7.4.3 Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Stomach Cancer and Gastric Cancer Drugs Market Size (2018-2029)
8.2 China Stomach Cancer and Gastric Cancer Drugs Market Size by Type
8.2.1 China Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2018-2024)
8.2.2 China Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2024-2029)
8.2.3 China Stomach Cancer and Gastric Cancer Drugs Market Share by Type (2018-2029)
8.3 China Stomach Cancer and Gastric Cancer Drugs Market Size by Application
8.3.1 China Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2018-2024)
8.3.2 China Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2024-2029)
8.3.3 China Stomach Cancer and Gastric Cancer Drugs Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Stomach Cancer and Gastric Cancer Drugs Market Size (2018-2029)
9.2 Asia Stomach Cancer and Gastric Cancer Drugs Market Size by Type
9.2.1 Asia Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2018-2024)
9.2.2 Asia Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2024-2029)
9.2.3 Asia Stomach Cancer and Gastric Cancer Drugs Market Share by Type (2018-2029)
9.3 Asia Stomach Cancer and Gastric Cancer Drugs Market Size by Application
9.3.1 Asia Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2018-2024)
9.3.2 Asia Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2024-2029)
9.3.3 Asia Stomach Cancer and Gastric Cancer Drugs Market Share by Application (2018-2029)
9.4 Asia Stomach Cancer and Gastric Cancer Drugs Market Size by Region
9.4.1 Asia Stomach Cancer and Gastric Cancer Drugs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Stomach Cancer and Gastric Cancer Drugs Market Size by Region (2018-2024)
9.4.3 Asia Stomach Cancer and Gastric Cancer Drugs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Stomach Cancer and Gastric Cancer Drugs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Stomach Cancer and Gastric Cancer Drugs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Stomach Cancer and Gastric Cancer Drugs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Ipsen Pharma
11.1.1 Ipsen Pharma Company Details
11.1.2 Ipsen Pharma Business Overview
11.1.3 Ipsen Pharma Stomach Cancer and Gastric Cancer Drugs Introduction
11.1.4 Ipsen Pharma Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024)
11.1.5 Ipsen Pharma Recent Developments
11.2 Merck & Co., Inc.
11.2.1 Merck & Co., Inc. Company Details
11.2.2 Merck & Co., Inc. Business Overview
11.2.3 Merck & Co., Inc. Stomach Cancer and Gastric Cancer Drugs Introduction
11.2.4 Merck & Co., Inc. Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024)
11.2.5 Merck & Co., Inc. Recent Developments
11.3 Bristol-Myers Squibb Company
11.3.1 Bristol-Myers Squibb Company Company Details
11.3.2 Bristol-Myers Squibb Company Business Overview
11.3.3 Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Drugs Introduction
11.3.4 Bristol-Myers Squibb Company Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024)
11.3.5 Bristol-Myers Squibb Company Recent Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Stomach Cancer and Gastric Cancer Drugs Introduction
11.4.4 Eli Lilly Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024)
11.4.5 Eli Lilly Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Stomach Cancer and Gastric Cancer Drugs Introduction
11.5.4 Roche Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024)
11.5.5 Roche Recent Developments
11.6 Novartis AG
11.6.1 Novartis AG Company Details
11.6.2 Novartis AG Business Overview
11.6.3 Novartis AG Stomach Cancer and Gastric Cancer Drugs Introduction
11.6.4 Novartis AG Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024)
11.6.5 Novartis AG Recent Developments
11.7 Bayer AG
11.7.1 Bayer AG Company Details
11.7.2 Bayer AG Business Overview
11.7.3 Bayer AG Stomach Cancer and Gastric Cancer Drugs Introduction
11.7.4 Bayer AG Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024)
11.7.5 Bayer AG Recent Developments
11.8 Celltrion Inc.
11.8.1 Celltrion Inc. Company Details
11.8.2 Celltrion Inc. Business Overview
11.8.3 Celltrion Inc. Stomach Cancer and Gastric Cancer Drugs Introduction
11.8.4 Celltrion Inc. Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024)
11.8.5 Celltrion Inc. Recent Developments
11.9 TAIHO PHARMACEUTICAL CO., LTD.
11.9.1 TAIHO PHARMACEUTICAL CO., LTD. Company Details
11.9.2 TAIHO PHARMACEUTICAL CO., LTD. Business Overview
11.9.3 TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Drugs Introduction
11.9.4 TAIHO PHARMACEUTICAL CO., LTD. Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024)
11.9.5 TAIHO PHARMACEUTICAL CO., LTD. Recent Developments
11.10 Jiangsu Hengrui Medicine Co., Ltd.
11.10.1 Jiangsu Hengrui Medicine Co., Ltd. Company Details
11.10.2 Jiangsu Hengrui Medicine Co., Ltd. Business Overview
11.10.3 Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Drugs Introduction
11.10.4 Jiangsu Hengrui Medicine Co., Ltd. Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024)
11.10.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Stomach Cancer and Gastric Cancer Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Programmed Cell Death Protein 1 (PD-1) Inhibitors
Table 3. Key Players of Human Epidermal Growth Factor Receptor (HER2) Antagonists
Table 4. Key Players of Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
Table 5. Key Players of Others
Table 6. Global Stomach Cancer and Gastric Cancer Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Stomach Cancer and Gastric Cancer Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Stomach Cancer and Gastric Cancer Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Stomach Cancer and Gastric Cancer Drugs Market Share by Region (2018-2024)
Table 10. Global Stomach Cancer and Gastric Cancer Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Stomach Cancer and Gastric Cancer Drugs Market Share by Region (2024-2029)
Table 12. Stomach Cancer and Gastric Cancer Drugs Market Trends
Table 13. Stomach Cancer and Gastric Cancer Drugs Market Drivers
Table 14. Stomach Cancer and Gastric Cancer Drugs Market Challenges
Table 15. Stomach Cancer and Gastric Cancer Drugs Market Restraints
Table 16. Global Stomach Cancer and Gastric Cancer Drugs Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Stomach Cancer and Gastric Cancer Drugs Revenue Share by Players (2018-2024)
Table 18. Global Top Stomach Cancer and Gastric Cancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stomach Cancer and Gastric Cancer Drugs as of 2022)
Table 19. Global Stomach Cancer and Gastric Cancer Drugs Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Stomach Cancer and Gastric Cancer Drugs Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Stomach Cancer and Gastric Cancer Drugs, Headquarters and Area Served
Table 22. Global Key Players of Stomach Cancer and Gastric Cancer Drugs, Product and Application
Table 23. Global Key Players of Stomach Cancer and Gastric Cancer Drugs, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Stomach Cancer and Gastric Cancer Drugs Revenue Market Share by Type (2018-2024)
Table 27. Global Stomach Cancer and Gastric Cancer Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Stomach Cancer and Gastric Cancer Drugs Revenue Market Share by Type (2024-2029)
Table 29. Global Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Stomach Cancer and Gastric Cancer Drugs Revenue Share by Application (2018-2024)
Table 31. Global Stomach Cancer and Gastric Cancer Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Stomach Cancer and Gastric Cancer Drugs Revenue Share by Application (2024-2029)
Table 33. North America Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Stomach Cancer and Gastric Cancer Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Stomach Cancer and Gastric Cancer Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Stomach Cancer and Gastric Cancer Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Stomach Cancer and Gastric Cancer Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Stomach Cancer and Gastric Cancer Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Stomach Cancer and Gastric Cancer Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 65. Ipsen Pharma Company Details
Table 66. Ipsen Pharma Business Overview
Table 67. Ipsen Pharma Stomach Cancer and Gastric Cancer Drugs Product
Table 68. Ipsen Pharma Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024) & (US$ Million)
Table 69. Ipsen Pharma Recent Developments
Table 70. Merck & Co., Inc. Company Details
Table 71. Merck & Co., Inc. Business Overview
Table 72. Merck & Co., Inc. Stomach Cancer and Gastric Cancer Drugs Product
Table 73. Merck & Co., Inc. Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024) & (US$ Million)
Table 74. Merck & Co., Inc. Recent Developments
Table 75. Bristol-Myers Squibb Company Company Details
Table 76. Bristol-Myers Squibb Company Business Overview
Table 77. Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Drugs Product
Table 78. Bristol-Myers Squibb Company Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024) & (US$ Million)
Table 79. Bristol-Myers Squibb Company Recent Developments
Table 80. Eli Lilly Company Details
Table 81. Eli Lilly Business Overview
Table 82. Eli Lilly Stomach Cancer and Gastric Cancer Drugs Product
Table 83. Eli Lilly Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024) & (US$ Million)
Table 84. Eli Lilly Recent Developments
Table 85. Roche Company Details
Table 86. Roche Business Overview
Table 87. Roche Stomach Cancer and Gastric Cancer Drugs Product
Table 88. Roche Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024) & (US$ Million)
Table 89. Roche Recent Developments
Table 90. Novartis AG Company Details
Table 91. Novartis AG Business Overview
Table 92. Novartis AG Stomach Cancer and Gastric Cancer Drugs Product
Table 93. Novartis AG Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024) & (US$ Million)
Table 94. Novartis AG Recent Developments
Table 95. Bayer AG Company Details
Table 96. Bayer AG Business Overview
Table 97. Bayer AG Stomach Cancer and Gastric Cancer Drugs Product
Table 98. Bayer AG Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024) & (US$ Million)
Table 99. Bayer AG Recent Developments
Table 100. Celltrion Inc. Company Details
Table 101. Celltrion Inc. Business Overview
Table 102. Celltrion Inc. Stomach Cancer and Gastric Cancer Drugs Product
Table 103. Celltrion Inc. Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024) & (US$ Million)
Table 104. Celltrion Inc. Recent Developments
Table 105. TAIHO PHARMACEUTICAL CO., LTD. Company Details
Table 106. TAIHO PHARMACEUTICAL CO., LTD. Business Overview
Table 107. TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Drugs Product
Table 108. TAIHO PHARMACEUTICAL CO., LTD. Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024) & (US$ Million)
Table 109. TAIHO PHARMACEUTICAL CO., LTD. Recent Developments
Table 110. Jiangsu Hengrui Medicine Co., Ltd. Company Details
Table 111. Jiangsu Hengrui Medicine Co., Ltd. Business Overview
Table 112. Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Drugs Product
Table 113. Jiangsu Hengrui Medicine Co., Ltd. Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024) & (US$ Million)
Table 114. Jiangsu Hengrui Medicine Co., Ltd. Recent Developments
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Stomach Cancer and Gastric Cancer Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Stomach Cancer and Gastric Cancer Drugs Market Share by Type: 2022 VS 2029
Figure 3. Programmed Cell Death Protein 1 (PD-1) Inhibitors Features
Figure 4. Human Epidermal Growth Factor Receptor (HER2) Antagonists Features
Figure 5. Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists Features
Figure 6. Others Features
Figure 7. Global Stomach Cancer and Gastric Cancer Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Stomach Cancer and Gastric Cancer Drugs Market Share by Application: 2022 VS 2029
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Stomach Cancer and Gastric Cancer Drugs Report Years Considered
Figure 12. Global Stomach Cancer and Gastric Cancer Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Stomach Cancer and Gastric Cancer Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Stomach Cancer and Gastric Cancer Drugs Market Share by Region: 2022 VS 2029
Figure 15. Global Stomach Cancer and Gastric Cancer Drugs Market Share by Players in 2022
Figure 16. Global Top Stomach Cancer and Gastric Cancer Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stomach Cancer and Gastric Cancer Drugs as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Stomach Cancer and Gastric Cancer Drugs Revenue in 2022
Figure 18. North America Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Stomach Cancer and Gastric Cancer Drugs Market Share by Type (2018-2029)
Figure 20. North America Stomach Cancer and Gastric Cancer Drugs Market Share by Application (2018-2029)
Figure 21. North America Stomach Cancer and Gastric Cancer Drugs Market Share by Country (2018-2029)
Figure 22. United States Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Stomach Cancer and Gastric Cancer Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Stomach Cancer and Gastric Cancer Drugs Market Share by Type (2018-2029)
Figure 26. Europe Stomach Cancer and Gastric Cancer Drugs Market Share by Application (2018-2029)
Figure 27. Europe Stomach Cancer and Gastric Cancer Drugs Market Share by Country (2018-2029)
Figure 28. Germany Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Stomach Cancer and Gastric Cancer Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Stomach Cancer and Gastric Cancer Drugs Market Share by Type (2018-2029)
Figure 36. China Stomach Cancer and Gastric Cancer Drugs Market Share by Application (2018-2029)
Figure 37. Asia Stomach Cancer and Gastric Cancer Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Stomach Cancer and Gastric Cancer Drugs Market Share by Type (2018-2029)
Figure 39. Asia Stomach Cancer and Gastric Cancer Drugs Market Share by Application (2018-2029)
Figure 40. Asia Stomach Cancer and Gastric Cancer Drugs Market Share by Region (2018-2029)
Figure 41. Japan Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Stomach Cancer and Gastric Cancer Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Stomach Cancer and Gastric Cancer Drugs Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Stomach Cancer and Gastric Cancer Drugs Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Stomach Cancer and Gastric Cancer Drugs Market Share by Country (2018-2029)
Figure 51. Brazil Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Ipsen Pharma Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024)
Figure 58. Merck & Co., Inc. Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024)
Figure 59. Bristol-Myers Squibb Company Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024)
Figure 60. Eli Lilly Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024)
Figure 61. Roche Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024)
Figure 62. Novartis AG Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024)
Figure 63. Bayer AG Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024)
Figure 64. Celltrion Inc. Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024)
Figure 65. TAIHO PHARMACEUTICAL CO., LTD. Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024)
Figure 66. Jiangsu Hengrui Medicine Co., Ltd. Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2018-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed